Oncternal Therapeutics (NASDAQ:ONCT) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a report published on Monday. The firm issued a sell rating on the stock. A number of other brokerages have also recently issued reports on ONCT. Oppenheimer cut shares of Oncternal Therapeutics from an outperform rating to a market perform rating in […]

Related Keywords

San Diego ,California ,United States ,Jamesb Breitmeyer ,Davidf Hale , ,Healthcare Of Ontario Pension Plan Trust Fund ,Maxim Group ,Cantor Fitzgerald ,Waypoint Capital Advisors ,Renaissance Technologies ,Oncternal Therapeutics Inc ,Oncternal Therapeutics ,Get Rating ,Capital Management ,Capital Acquisition ,Therapeutics Stock Down ,Capital Advisors ,Ontario Pension Plan Trust Fund ,Sigma Investments ,Two Sigma Advisers ,Sigma Advisers ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Initiated Coverage ,Stocknews Com ,